The class of PPIAL4G activators refers to a group of chemical compounds designed to interact with and modulate the activity of the PPIAL4G protein. PPIAL4G, also known as Peptidyl-prolyl cis-trans isomerase A-like 4G, is a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family of proteins. These proteins are known for their ability to catalyze the cis-trans isomerization of peptide bonds, thereby influencing protein folding, stability, and function. While the specific functions of PPIAL4G are still being elucidated, it is believed to play important roles in cellular processes such as protein folding, trafficking, and signaling. The term activators suggests that these compounds interact with PPIAL4G to modulate its enzymatic activity or influence its interactions with other proteins, potentially leading to downstream effects on cellular physiology.
Research into PPIAL4G activators involves investigating the molecular mechanisms underlying their interaction with the PPIAL4G protein and how this interaction impacts cellular processes. Understanding the pharmacological properties of these compounds is essential for deciphering how they affect PPIAL4G activity and potentially influence protein folding and cellular function. By elucidating the biological functions and regulatory mechanisms of PPIAL4G, researchers aim to expand our understanding of fundamental cellular processes and may uncover novel targets for further study. Continued exploration of PPIAL4G activators holds promise for advancing our knowledge of protein folding dynamics and may provide insights into new strategies for manipulating cellular function in experimental contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen, a selective estrogen receptor modulator, could potentially influence the expression of genes like PPIAL4G through estrogen receptor pathways. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
As an antioxidant, Vitamin C can influence gene expression by modulating redox-sensitive transcription factors, potentially affecting PPIAL4G. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, which can lead to changes in cellular growth and gene expression, potentially including PPIAL4G. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Acting as an aldosterone antagonist, spironolactone can influence gene expression through mineralocorticoid receptors, possibly affecting PPIAL4G. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Can induce DNA damage response, potentially influencing gene expression, including PPIAL4G. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
As a thiazolidinedione, pioglitazone activates PPARγ, influencing the expression of genes involved in metabolism, potentially including PPIAL4G. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can modulate various cellular pathways, potentially influencing gene expression, including PPIAL4G. | ||||||
Isoniazid | 54-85-3 | sc-205722 sc-205722A sc-205722B | 5 g 50 g 100 g | $26.00 $101.00 $146.00 | ||
Isoniazid can induce oxidative stress, potentially affecting the expression of various genes, including PPIAL4G. | ||||||
Acetaminophen | 103-90-2 | sc-203425 sc-203425A sc-203425B | 25 g 100 g 500 g | $41.00 $61.00 $194.00 | 11 | |
Potentially leading to changes in gene expression profiles, including PPIAL4G. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate can affect DNA synthesis and repair, potentially influencing the expression of a wide range of genes, including PPIAL4G. | ||||||